Product Development
Aug. 11 Quick Takes: BMS hits, Genentech misses; plus JW-Lyell, CStone, Big Health
Aug 12, 2020 | 3:10 AM GMT
Opdivo clears Phase III hurdles in gastric, esophageal cancers
Opdivo nivolumab from Bristol Myers Squibb Co. (NYSE:BMY) plus chemotherapy led to a survival benefit compared with chemotherapy alone in
